Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the branded generics market size evolved in recent years?

In the past few years, the market size for branded generics has seen significant growth. From a value of $363.49 billion in 2024, it is expected to increase to $397.19 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.3%. Factors such as affordability and cost savings, patent expirations, expansion and accessibility of the market, government policies and initiatives, and healthcare reforms have been instrumental in this historic growth.

What are the predictions for the branded generics market size in the coming years?

In the coming years, the specialty insurance market size is anticipated to undergo swift expansion. Projections show an increment to $164.25 billion by 2029, with a compound annual growth rate (CAGR) of 10.7%. Factors contributing to growth in the projected period include impending cyber threats, the effects of climate change, readiness for pandemics, advancement in technology, development in the healthcare industry, and a changing legal scenario. The predicted trends encompass tailor-made insurance solutions for the cannabis sector, thriving demand for space insurance in the aerospace industry, exclusive coverage for fine art pieces and collectibles, proliferation of insurance for renewable energy ventures, and a heightened emphasis on employee benefits liability coverage.

Get your branded generics market report here!

https://www.thebusinessresearchcompany.com/report/branded-generics-global-market-report

What key factors are fueling the growth of the branded generics market?

The escalating occurrence of long-lasting illnesses, often curable but usually not healable, commonly known as chronic diseases, is propelling the upward trajectory of the branded generics market. The surge in chronic diseases correlates significantly with poor nutrition, increased tobacco use, lack of physical activity, and overconsumption of alcohol among others. This surge has globally influenced consumer behavior, with individuals opting for branded generics as a more cost-effective solution for treating chronic conditions compared to conventional medicines. As laid out in the World Health Organization’s (WHO) 2022 Highlights in September 2022, a Switzerland-based intergovernmental health body reiterated that noncommunicable diseases (NCDs) or chronic diseases were responsible for 41 million deaths, constituting 74% of global mortality. Therefore, the swelling prevalence of chronic conditions is likely to stimulate further demand for branded generics in the coming period.

How is the global branded generics market divided into key segments?

The branded generics market covered in this report is segmented –

1) By Drug Class: Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptics, Other Drugs

2) By Route Of Administration: Topical, Oral, Parenteral, Other Routes Of Administration

3) By Application: Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics And Anti-inflammatory, Other Applications

Subsegments:

1) By Alkylating Agents: Nitrogen Mustards, Ethylene Imine Compounds

2) By Antimetabolites: Purine Analogues, Pyrimidine Analogues

3) By Hormones: Corticosteroids, Thyroid Hormones

4) By Anti-Hypertensive: ACE Inhibitors, Beta Blockers, Calcium Channel Blockers

5) By Lipid Lowering Drugs: Statins, Fibrates

6) By Anti-Depressants: SSRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)

7) By Anti-Psychotics: Atypical Antipsychotics, Typical Antipsychotics

8) By Anti-Epileptics: Sodium Channel Blockers, GABAergic Drugs

9) By Other Drugs: Analgesics, Antibiotics, Antivirals

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7186&type=smp

Who are the key firms paving the way for growth in the branded generics market?

Major companies operating in the branded generics market include Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, AstraZeneca plc, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Mylan N.V., Sandoz International GmbH, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Apotex Inc., Aspen Pharmacare Holdings Limited, Endo International plc, Towa Pharmaceutical Co. Ltd., Mankind Pharma, Glenmark Pharmaceuticals, Par Pharmaceuticals Inc., Unichem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Wockhardt, Intas Pharmaceuticals Ltd., Novartis International AG, Novo Nordisk A/S, Zydus Lifesciences Ltd.

Which trends are expected to transform the branded generics market?

Collaborative strategic alliances have emerged as a prominent trend in the branded generics sector. Firms in this industry are forging alliances with suitable partners to mutually benefit from shared resources and penetrate new markets. For example, in September 2024, Biocon Ltd., a pharmaceutical entity from India, formed a partnership with Tabuk Pharmaceuticals. Under this collaboration, Biocon is tasked with developing and manufacturing GLP-1 products, thereby ensuring the availability of high-quality biopharmaceuticals for diabetes treatment. Tabuk Pharmaceuticals retains the rights for marketing authorization and will oversee the registration, importation, and promotion of these products in the Middle East, especially Saudi Arabia. The terms of the agreement entail scope for future extension to other GLP products than those initially offered, thereby facilitating a wider spectrum of diabetes treatments. The goal of this partnership is to provide distinctive health solutions that improve patient welfare in Saudi Arabia and its peripheries, keeping with the commitment of both companies to enhance healthcare accessibility. Tabuk Pharmaceuticals is a pharmaceutical firm based in Saudi Arabia that trades in both branded and generic pharmaceutical products.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7186

What regions are contributing significantly to the growth of the branded generics market?

North America was the largest region in the branded generics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the branded generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Gastrointestinal Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Pharmacies and Drug Stores Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmacies-and-drug-stores-global-market-report

Vitamin and Minerals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vitamin-and-mineral-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: